Short-term survivors with brain metastases have modest benefits from focal and systemic therapies and remain frequent despite improving treatment landscapeM. Czogalla, Clemens Seidel, Nils Gleim et al.|Clinical and Translational Radiation Oncology|2025Cited by 2